PUBLISHER: IMARC | PRODUCT CODE: 1541699
PUBLISHER: IMARC | PRODUCT CODE: 1541699
Intravenous (IV) Ibuprofen Market Report by Product Dose (100 Mg Dose, 200 Mg Dose, 400 Mg Dose, 800 Mg Dose), Indication (Pain/Inflammatory, Fever), Age Group (Pediatrics, Adults), and Region 2024-2032
The global intravenous (IV) ibuprofen market size reached US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.79% during 2024-2032.
Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body's production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.
Intravenous (IV) Ibuprofen Market Trends:
The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor. Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth. Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous (IV) ibuprofen market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product dose, indication and age group.
Breakup by Product Dose:
100 Mg Dose
200 Mg Dose
400 Mg Dose
800 Mg Dose
Breakup by Indication:
Pain/Inflammatory
Fever
Breakup by Age Group:
Pediatrics
Adults
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.
Key Questions Answered in This Report
- 1. What was the size of the global Intravenous (IV) ibuprofen market in 2023?
- 2. What is the expected growth rate of the global Intravenous (IV) ibuprofen market during 2024-2032?
- 3. What are the key factors driving the global Intravenous (IV) ibuprofen market?
- 4. What has been the impact of COVID-19 on the global Intravenous (IV) ibuprofen market?
- 5. What is the breakup of the global Intravenous (IV) ibuprofen market based on the indication?
- 6. What is the breakup of the global Intravenous (IV) ibuprofen market based on the age group?
- 7. What are the key regions in the global Intravenous (IV) ibuprofen market?
- 8. Who are the key players/companies in the global Intravenous (IV) ibuprofen market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Intravenous (IV) Ibuprofen Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Dose
- 6.1 100 Mg Dose
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 200 Mg Dose
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 400 Mg Dose
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 800 Mg Dose
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Indication
- 7.1 Pain/Inflammatory
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Fever
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Age Group
- 8.1 Pediatrics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Adults
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Cumberland Pharmaceuticals Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 Hyloris Pharmaceuticals SA
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.3 Recordati Rare Diseases Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 VALMOR Laboratories CA
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Xgen Pharmaceuticals Djb Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.1 Cumberland Pharmaceuticals Inc.
List of Figures
- Figure 1: Global: Intravenous Ibuprofen Market: Major Drivers and Challenges
- Figure 2: Global: Intravenous Ibuprofen Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2023
- Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2023
- Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2023
- Figure 7: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2023
- Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 9: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 11: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 13: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 15: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 17: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 18: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 19: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 21: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 22: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 23: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 24: North America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 25: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 26: United States: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 27: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 28: Canada: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 29: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 30: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 31: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 32: China: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 33: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 34: Japan: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 35: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 36: India: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 37: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 38: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 39: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 40: Australia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 41: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 42: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 43: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 44: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 45: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 46: Europe: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 47: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 48: Germany: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 49: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 50: France: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 51: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 52: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 53: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 54: Italy: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 55: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 56: Spain: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 57: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 58: Russia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 59: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 60: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 61: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 62: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 63: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 64: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 65: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 66: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 67: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 68: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 69: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2018 & 2023
- Figure 71: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2023
- Figure 72: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Global: Intravenous Ibuprofen Industry: SWOT Analysis
- Figure 74: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
- Figure 75: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Intravenous Ibuprofen Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Intravenous Ibuprofen Market Forecast: Breakup by Product Dose (in Million US$), 2024-2032
- Table 3: Global: Intravenous Ibuprofen Market Forecast: Breakup by Indication (in Million US$), 2024-2032
- Table 4: Global: Intravenous Ibuprofen Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
- Table 5: Global: Intravenous Ibuprofen Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Intravenous Ibuprofen Market: Competitive Structure
- Table 7: Global: Intravenous Ibuprofen Market: Key Players
